Regeneus Ltd (RGS) was on track to complete its clinical collaboration with a Japanese partner for Progenza in Japan in the near-term. The company had disclosed that it anticipated completing the collaboration before the end of 30 June but discussions have taken longer than originally anticipated. Part of this delay is due to there being several interested parties in active discussions for licensing Progenza.
http://crweworld.com/australia/tren...-rgsax-update-on-licensing-progenza-in-japan-
Regeneus Ltd (RGS) was on track to complete its clinical...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
